Steven Cohen Olema Pharmaceuticals, Inc. Transaction History
Point72 Asset Management, L.P.
- $36 Billion
- Q2 2024
A detailed history of Steven Cohen (Point72 Asset Management, L.P.) transactions in Olema Pharmaceuticals, Inc. stock. As of the latest transaction made, Point72 Asset Management, L.P. holds 3,211,927 shares of OLMA stock, worth $39.8 Million. This represents 0.1% of its overall portfolio holdings.
Number of Shares
3,211,927
Previous 3,211,927
-0.0%
Holding current value
$39.8 Million
Previous $34.8 Million
-0.0%
% of portfolio
0.1%
Previous 0.1%
Shares
4 transactions
Others Institutions Holding OLMA
# of Institutions
130Shares Held
57.6MCall Options Held
57.5KPut Options Held
34K-
Bvf Inc San Francisco, CA9.14MShares$113 Million3.02% of portfolio
-
Paradigm Biocapital Advisors LP New York, NY7.9MShares$98 Million3.46% of portfolio
-
Deep Track Capital, LP Greenwich, CT4MShares$49.6 Million1.42% of portfolio
-
Black Rock Inc. New York, NY4MShares$49.6 Million0.0% of portfolio
-
Logos Global Management LP San Francisco, CA3.21MShares$39.8 Million3.26% of portfolio
About Olema Pharmaceuticals, Inc.
- Ticker OLMA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 40,419,600
- Market Cap $501M
- Description
- Olema Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies for women's cancers. Its lead product candidate is OP-1250, an estrogen receptor (ER) antagonist and a selective ER degrader, which is in Phase 1/2 clinical trial for the treatment of recurrent, local...